SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results
SANUWAVE Health (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, has scheduled a conference call to discuss its Q4 and Full Year 2024 financial results. The call will take place on March 21, 2025, at 8:30 AM ET.
Investors can access the call through toll-free (1-800-245-3047) or international (1-203-518-9765) numbers using Conference ID: SANUWAVE. Supporting materials will be available on the company's investor relations website. A replay of the call will be accessible through April 11, 2025, using the replay access ID: 11157832.
SANUWAVE Health (NASDAQ: SNWV), un fornitore leader di prodotti per la cura delle ferite di nuova generazione approvati dalla FDA, ha programmato una conferenza telefonica per discutere i suoi risultati finanziari del Q4 e dell'intero anno 2024. La chiamata avrà luogo il 21 marzo 2025, alle 8:30 AM ET.
Gli investitori possono accedere alla chiamata tramite numeri gratuiti (1-800-245-3047) o internazionali (1-203-518-9765) utilizzando l'ID Conferenza: SANUWAVE. I materiali di supporto saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda. Una registrazione della chiamata sarà accessibile fino all'11 aprile 2025, utilizzando l'ID di accesso alla registrazione: 11157832.
SANUWAVE Health (NASDAQ: SNWV), un proveedor líder de productos de cuidado de heridas de próxima generación aprobados por la FDA, ha programado una llamada de conferencia para discutir sus resultados financieros del Q4 y del año completo 2024. La llamada tendrá lugar el 21 de marzo de 2025, a las 8:30 AM ET.
Los inversores pueden acceder a la llamada a través de números gratuitos (1-800-245-3047) o internacionales (1-203-518-9765) utilizando el ID de Conferencia: SANUWAVE. Los materiales de apoyo estarán disponibles en el sitio web de relaciones con inversores de la empresa. Una repetición de la llamada estará accesible hasta el 11 de abril de 2025, utilizando el ID de acceso a la repetición: 11157832.
SANUWAVE Health (NASDAQ: SNWV), FDA 승인을 받은 차세대 상처 치료 제품의 선도적인 제공업체로, 2024년 4분기 및 연간 재무 결과에 대해 논의하기 위한 컨퍼런스 콜을 예정했습니다. 이 콜은 2025년 3월 21일 오전 8시 30분 ET에 진행됩니다.
투자자들은 무료 전화번호(1-800-245-3047) 또는 국제 전화번호(1-203-518-9765)를 통해 SANUWAVE 회의 ID를 사용하여 콜에 접속할 수 있습니다. 지원 자료는 회사의 투자자 관계 웹사이트에서 제공될 것입니다. 콜의 재생은 2025년 4월 11일까지 접근할 수 있으며, 재생 접근 ID는 11157832입니다.
SANUWAVE Health (NASDAQ: SNWV), un fournisseur leader de produits de soins des plaies de nouvelle génération approuvés par la FDA, a programmé une conférence téléphonique pour discuter de ses résultats financiers du 4ème trimestre et de l'année complète 2024. L'appel aura lieu le 21 mars 2025 à 8h30 ET.
Les investisseurs peuvent accéder à l'appel via des numéros gratuits (1-800-245-3047) ou internationaux (1-203-518-9765) en utilisant l'ID de conférence : SANUWAVE. Les documents de soutien seront disponibles sur le site des relations investisseurs de l'entreprise. Un enregistrement de l'appel sera accessible jusqu'au 11 avril 2025, en utilisant l'ID d'accès à l'enregistrement : 11157832.
SANUWAVE Health (NASDAQ: SNWV), ein führender Anbieter von FDA-zugelassenen Wundversorgungsprodukten der nächsten Generation, hat eine Telefonkonferenz angesetzt, um die finanziellen Ergebnisse des 4. Quartals und des gesamten Jahres 2024 zu besprechen. Die Konferenz findet am 21. März 2025 um 8:30 Uhr ET statt.
Investoren können über gebührenfreie (1-800-245-3047) oder internationale (1-203-518-9765) Nummern mit der Konferenz-ID: SANUWAVE auf die Konferenz zugreifen. Unterstützende Materialien werden auf der Investor-Relations-Website des Unternehmens verfügbar sein. Eine Wiederholung der Konferenz wird bis zum 11. April 2025 zugänglich sein, mit der Wiederholungszugangs-ID: 11157832.
- None.
- None.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-245-3047
Toll/International: 1-203-518-9765
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event: https://viavid.webcasts.com/starthere.jsp?ei=1703280&tp_key=c099e4f4d9
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through April 11, 2025:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11157832
About SANUWAVE
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with supply chain and production constraints, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317118897/en/
Source: SANUWAVE Health, Inc.
FAQ
When will SANUWAVE (SNWV) report Q4 and Full Year 2024 earnings?
How can investors access SANUWAVE's (SNWV) Q4 2024 earnings call?
Until when will SANUWAVE's (SNWV) Q4 2024 earnings call replay be available?
Where can investors find SANUWAVE's (SNWV) Q4 2024 earnings materials?
